Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients
Clinical trial NCT00904371 · COMPLETED
Trial details
- NCT number
- NCT00904371
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-01-01
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.